Mark Alan Goldberg Insider Trading $BPMC Blueprint Medicines Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in GLYCOMIMETICS INC ($GLYC) and Director in aTYR PHARMA INC ($LIFE) and Director in Blueprint Medicines Corp ($BPMC) and Director in Audentes Therapeutics, Inc. ($BOLD).
Mark Alan Goldberg in Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Alan Goldberg: Director
Holdings: 9,017 shares
Current Value: $323,169
Latest Transaction: Dec 28 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark Alan Goldberg in Blueprint Medicines Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 0 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 125.00 | 5,455 | 681,875 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 5,455 | |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 120.00 | 5,454 | 654,480 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 22 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 10,909 | |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 115.00 | 5,455 | 627,325 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Dec 15 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,455 | 153,558 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,454 | 153,530 | 16,364 | |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 110.00 | 5,454 | 599,940 | 3,562 | 9 K to 3.6 K (-60.49 %) |
| Dec 03 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 28.15 | 5,454 | 153,530 | 9,016 | 3.6 K to 9 K (+153.12 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 19.53 | 5,455 | 106,536 | 0 | |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 105.00 | 5,455 | 572,775 | 3,562 | 9 K to 3.6 K (-60.50 %) |
| Oct 21 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 19.53 | 5,455 | 106,536 | 9,017 | 3.6 K to 9 K (+153.14 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 25 2018 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 69.79 | 7,500 | 523,425 | 51,136 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 27 2016 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 |
Page: 1